Wiener klinische Wochenschrift

, Volume 126, Issue 9–10, pp 291–293

Acute kidney injury with medazepam-hyoscine buthylbromide

case report


An 84-year-old female patient was admitted to our internal medicine outpatient clinic complaining of stomach ache, nausea, and vomiting. She had hepatitis C infection for 10 years that was managed with antiviral treatment. On the second day of admission, she developed anxiety and complained about dysuria. Medazepam and hyoscine butylbromide combined tablet was administered. The day after medazepam and hyoscine butylbromide administration, patient’s creatinine level increased to 2.3 mg/dL (0.57–1.11 mg/dL). Medazepam and hyoscine butylbromide administration was stopped on the fourth day. After 10 days of follow-up, her creatinine levels were normalized. In this article, we present an elderly patient with acute kidney injury induced by medazepam and hyoscine butylbromide that was managed with best supportive care.


Medazepam and hyoscine butylbromide Acute renal failure Elderly patients 

Akutes Nierenversagen durch Medazepam-Hyoscin Butylbromid


Eine 84-jährige Patientin präsentierte sich in unserer Ambulanz für Innere Medizin mit Magenschmerzen, Übelkeit und Erbrechen. Sie hatte seit 10 Jahren eine Infektion mit Hepatitis C, die unter antiviraler Therapie stand. Am 2. Tag nach der stationären Aufnahme klagte sie über Beklemmungen und Dysurie. Sie erhielt Medazepam und Hyoscin Butylbromid in einer Kombinationstablette. Am Tag nach der Verabreichung stieg das Kreatinin auf 2,3 mg/dL (0,57–1,11 mg/dL). Die kombinierte Gabe von Medazepam und Hyoscin Butylbromid wurde am Tag 4 beendet. Bei der Kontrolle 10 Tage später waren die Kreatinin Spiegel wieder im Normbereich.

Im vorliegenden Artikel berichten wir über eine ältere Patientin mit einem durch Medazepam kombiniert mit Hyoscin Butylbromid induziertem akuten Nierenversagen, das sich nach Absetzen ohne weitere spezifische Maßnahmen wieder besserte.


Medazepam und Hyoscin Butylbromid Akutes Nierenversagen Ältere Patienten 


  1. 1.
    Buffett-Jerrott SE, Stewart SH. Cognitive and sedative effects of benzodiazepine use. Curr Pharm Des. 2002;8(1):45–58.Google Scholar
  2. 2.
    Charney DS, Mihic SJ, Harris RA. Chap. 17: Hypnotics and sedatives. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s the pharmacological basis of therapeutics. 12th ed, Section II, Neuropharmacology. New York: McGraw-Hill; 2011.Google Scholar
  3. 3.
    Tytgat GN. Hyoscine butylbromide: a review of its use in the treatment of abdominal cramping and pain. Drugs. 2007 June;67(9):1343–57.Google Scholar
  4. 4.
    Zar T, et al. Acute kidney injury, hyperosmolality and metabolic acidosis associated with lorazepam. Nat Clin Pract Nephrol. 2007;3:517–20.Google Scholar
  5. 5.
    Chap. 31: Benzodiazepines. In: Olson KR, editor. Poisoning & drug overdose. 6th ed. New York: McGraw-Hill; 2012.Google Scholar
  6. 6.
    Margolias G, Harris RS. Chap. 135: Analgesia paralytics and sedation. In: McKean SC, Ross JJ, Dressler DD, Brotman DJ, Ginsberg JS, editors. Principles and practice of hospital medicine. McGraw-Hill; 2012. pp. 1070–81.Google Scholar
  7. 7.
    Liangos O, Wald R, O’Bell JW, Price L, Pereira BJ, Jaber BL. Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey. Clin J Am Soc Nephrol. 2006;1(1):43.PubMedCrossRefGoogle Scholar
  8. 8.
    Rosner MH, Okusa MD. Drug-associated acute renal failure in the intensive care unit. In: De Broe ME, Porter GA, Bennett WM, Deray G, editors. Clinical nephrotoxins: renal injury from drugs and chemicals. 3rd ed. Boston: Kluwer Academic Press; 2008.Google Scholar
  9. 9.
    Chap. 57: Assessment and evaluation of the renal patient, acute kidney injury specific syndromes. In: McKean SC, Ross JJ, Dressler DD, Brotman DJ, Ginsberg JS, editors. Principles and practice of hospital medicine. McGraw-Hill; 2012. pp. 378–90.Google Scholar
  10. 10.
    Wyne A, Rai R, Cuerden M, Clark WF, Suri RS. Opioid and benzodiazepine use in end-stage renal disease: a systematic review. Clin J Am Soc Nephrol. 2011 Feb;6(2):326–33.Google Scholar
  11. 11.
    Unruh ML, Buysse DJ, Dew MA, Evans IV, Wu AW, Fink NE. Sleep quality and its correlates in the first year of dialysis. Clin J Am Soc Nephrol. 2006;1:802–10.Google Scholar
  12. 12.
    Hayman M, Seidl EC, Ali M, Malik K. Acute tubular necrosis associated with propylene glycol from concomitant administration of intravenous lorazepam and trimethoprim-sulfamethoxazole. Pharmacotherapy. 2003 Sept;23(9):1190–4.Google Scholar
  13. 13.
    Steinman MA, Hanlon JT. Managing medications in clinically complex elders: there’s got to be a happy medium. JAMA. 2010;304(14):1592.Google Scholar

Copyright information

© Springer-Verlag Wien 2014

Authors and Affiliations

  1. 1.Department of Internal MedicineGaziantep University Faculty of MedicineSahinbey, GaziantepTurkey
  2. 2.Division of Geriatric Medicine, Department of Internal MedicineGaziantep University Faculty of MedicineGaziantepTurkey

Personalised recommendations